![]() |
Volumn 48, Issue 1, 2002, Pages 30-33
|
Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve them
|
Author keywords
Drugs; Parkinson's disease; PD MED Trial; Randomised controlled trial
|
Indexed keywords
AMANTADINE;
BROMOCRIPTINE;
CABERGOLINE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
MONOAMINE OXIDASE B INHIBITOR;
PERGOLIDE;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
TOLCAPONE;
ADJUVANT THERAPY;
DOSE RESPONSE;
DRUG CHOICE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DYSKINESIA;
HEALTH CARE COST;
HUMAN;
MONOTHERAPY;
MOTOR DYSFUNCTION;
NEUROPROTECTION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
AGED;
ANTIPARKINSON AGENTS;
HUMANS;
PARKINSON DISEASE;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0036174571
PISSN: 0304324X
EISSN: None
Source Type: Journal
DOI: 10.1159/000048921 Document Type: Review |
Times cited : (7)
|
References (19)
|